Couchbase (BASE) Stock Forecast & Price Target

$13.92

-0.17 (-1.21%)

(As of 09/18/2024 ET)

Couchbase - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy
Based on 14 Analyst Ratings

Based on 14 Wall Street analysts who have issued ratings for Couchbase in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 14 analysts, 1 has given a sell rating, 3 have given a hold rating, and 10 have given a buy rating for BASE.

Consensus Price Target

$22.93
64.72% Upside

High Forecast	$30.00
Average Forecast	$22.93
Low Forecast	$18.00

According to the 14 analysts' twelve-month price targets for Couchbase, the average price target is $22.93. The highest price target for BASE is $30.00, while the lowest price target for BASE is $18.00. The average price target represents a forecasted upside of 64.72% from the current price of $13.92.

Type	Current Forecast 9/20/23 to 9/19/24	1 Month Ago 8/21/23 to 8/20/24	3 Months Ago 6/22/23 to 6/21/24	1 Year Ago 9/20/22 to 9/20/23
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	10 Buy rating(s)	11 Buy rating(s)	8 Buy rating(s)	6 Buy rating(s)
Hold	3 Hold rating(s)	3 Hold rating(s)	3 Hold rating(s)	3 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$22.93	$27.14	$29.36	$20.78
Forecasted Upside	64.72% Upside	36.20% Upside	37.95% Upside	23.98% Upside

This diversified cannabis pioneer could make huge moves soon (Ad)

The cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start with diversification and experience. Founded in 2005, this company serves a diverse and expansive customer base with more than 8,000 retail locations, including licensed cannabis dispensaries, smoke shops, and specialty retailers.

Learn more here.

BASE Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

BASE Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Couchbase Stock vs. The Competition

Type	Couchbase	Computer and Technology Companies	S&P 500
Consensus Rating Score	2.64	2.64	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	64.72% Upside	94.65% Upside	7.94% Upside
News Sentiment Rating	Positive News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
9/5/2024	Royal Bank of Canada 4 of 5 stars		Reiterated Rating	Outperform ➝ Outperform	$25.00 ➝ $25.00	+55.96%
9/5/2024	Wells Fargo & Company 3 of 5 stars		Lower Target	Overweight ➝ Overweight	$30.00 ➝ $23.00	+44.75%
9/5/2024	Oppenheimer 3 of 5 stars		Lower Target	Outperform ➝ Outperform	$25.00 ➝ $23.00	+41.10%
9/5/2024	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$30.00 ➝ $25.00	+51.06%
9/5/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Equal Weight ➝ Equal Weight	$20.00 ➝ $19.00	+14.80%
9/5/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$24.00 ➝ $19.00	+12.23%
This diversified cannabis pioneer could make huge moves soon (Ad) The cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start with diversification and experience. Founded in 2005, this company serves a diverse and expansive customer base with more than 8,000 retail locations, including licensed cannabis dispensaries, smoke shops, and specialty retailers. Learn more here.
9/5/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$25.00 ➝ $20.00	+5.32%
9/5/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Equal Weight ➝ Equal Weight	$29.00 ➝ $27.00	+42.18%
9/5/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$22.00 ➝ $21.00	+10.58%
9/5/2024	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Cikos Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$22.00 ➝ $22.00	+15.85%
9/5/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	$32.00 ➝ $27.00	+42.18%
8/16/2024	Piper Sandler Companies Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Overweight	$22.00	+22.84%
6/25/2024	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$30.00 ➝ $30.00	+72.12%
6/6/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Neutral ➝ Sell	$30.00 ➝ $18.00	-16.40%
9/7/2023	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform
12/14/2022	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Neutral	$16.00	+12.83%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 05:25 AM ET.

BASE Forecast - Frequently Asked Questions

What is Couchbase's forecast for 2024?: According to the research reports of 14 Wall Street equities research analysts, the average twelve-month stock price forecast for Couchbase is $22.93, with a high forecast of $30.00 and a low forecast of $18.00.
Should I buy or sell Couchbase stock right now?: 14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Couchbase in the last year. There is currently 1 sell rating, 3 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" BASE shares.
Does Couchbase's stock price have much upside?: According to analysts, Couchbase's stock has a predicted upside of 28.36% based on their 12-month stock forecasts.
What analysts cover Couchbase?: Couchbase has been rated by research analysts at Barclays, DA Davidson, Guggenheim, Morgan Stanley, Needham & Company LLC, Oppenheimer, Piper Sandler, Piper Sandler Companies, Robert W. Baird, Royal Bank of Canada, Stifel Nicolaus, UBS Group, and Wells Fargo & Company in the past 90 days.
Do Wall Street analysts like Couchbase more than its competitors?: Analysts like Couchbase less than other "computer and technology" companies. The consensus rating score for Couchbase is 2.64 while the average consensus rating score for "computer and technology" companies is 2.64. Learn more on how BASE compares to other companies.